Clinical Trial Update: Multiple-Ascending Dose Study [Phase 1]

View source ↗

Summary

A Phase 1 multiple-ascending-dose study in depression has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Depression | Phase 1 | Status: COMPLETED